Phase I/II trial of gemcitabine plus cisplatin and etoposide in patients with small-cell lung cancer
- 20 January 2003
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 39 (3) , 331-338
- https://doi.org/10.1016/s0169-5002(02)00500-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Irinotecan plus Cisplatin Compared with Etoposide plus Cisplatin for Extensive Small-Cell Lung CancerNew England Journal of Medicine, 2002
- Paclitaxel-based three-drug combinations for the treatment of small cell lung cancer: A review of The Sarah Cannon Cancer Center experienceSeminars in Oncology, 2001
- Phase II Trial of Paclitaxel and Carboplatin in Metastatic Small-Cell Lung Cancer: A Groupe Français de Pneumo-Cancérologie StudyJournal of Clinical Oncology, 2001
- New Chemotherapy Agents for Small Cell Lung CancerChest, 2000
- New Combinations in the Treatment of Lung CancerChest, 2000
- Management of Small Cell Lung CancerChest, 1999
- Cisplatin, Etoposide, and Paclitaxel in the Treatment of Patients With Extensive Small-Cell Lung CarcinomaJournal of Clinical Oncology, 1999
- Combination chemotherapy studies with gemcitabine and etoposide in non-small cell lung and ovarian cancer cell linesBiochemical Pharmacology, 1999
- Reporting results of cancer treatmentCancer, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958